Ads
related to: severe asthma attack- Treatment Information
Discover Educational Resources
& Get Financial Support Information
- Dosing And Administration
Get Info On Administration Options
Find Additional Support On The Site
- Home
Official Physician Website—
Get Treatment Info Today.
- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Patient Types
Identify The Appropriate Patient.
View Patient Types Today!
- Treatment Information
Search results
GSK’s asthma drug shows promise in reducing severe attacks
WHTC 1450 Holland· 6 days ago(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 6 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 6 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 6 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters via Yahoo News· 6 days agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for...
Too Few Asthma Patients Are Using Updated Inhalers | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 5 days agoImproved inhalers are now available to help control asthma and treat sudden attacks, but a new study...
Manage Your Asthma: FDA on Know Your Triggers and Treatment Options
Sierra Sun Times· 6 days agoAsthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via Yahoo Finance· 5 days agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...
Research finds few moderate or severe asthma patients prescribed recommended inhaler regimen
Medical Xpress· 6 days agoIn the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 5 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
